A recent study found that reducing blood pressure medications in frail elderly patients didn't increase mortality, making a higher blood pressure of up to 140 acceptable.

For frail older individuals with type 2 diabetes, a more lenient blood sugar target (HbA1c of 8%) is safer, as aggressive control increases the risk of falls.

For patients with both type 2 diabetes and heart failure, adding an SGLT2 inhibitor like Empagliflozin is strongly indicated to significantly reduce health risks.

In one study of nursing home residents, efforts to reduce unnecessary prescriptions slashed mortality risk by an impressive 26% and fall risks by 24%.

As we get older, the risks from medications can start to outweigh the benefits, turning them into what the speaker calls 'poison'.

Even mild hyponatremia (low sodium), often caused by combining blood pressure and antidepressant drugs, can increase the risk of falls in the elderly by 42%.

For those who haven't had a heart attack, clinical guidelines now suggest aspirin's 43% higher risk of major bleeding outweighs its modest benefits.

It is preferable to have several blood pressure medications at low doses rather than one at a high dose to achieve a greater effect with fewer side effects.